603590 康辰药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.6075.0273.4914.9606.316
总资产报酬率 ROA (%)2.9054.1762.9874.1355.269
投入资产回报率 ROIC (%)3.3684.8423.4264.8286.134

边际利润分析
销售毛利率 (%)89.36989.01785.44486.94092.673
营业利润率 (%)22.34215.57416.23423.74625.997
息税前利润/营业总收入 (%)21.98312.09514.12920.43319.767
净利润/营业总收入 (%)19.11220.38814.29520.67722.674

收益指标分析
经营活动净收益/利润总额(%)88.675119.22499.25972.60175.534
价值变动净收益/利润总额(%)9.5703.825-5.45018.8736.099
营业外收支净额/利润总额(%)-0.131-16.744-0.276-1.820-1.057

偿债能力分析
流动比率 (X)3.5523.8035.8996.1243.039
速动比率 (X)3.3613.6535.6845.8202.982
资产负债率 (%)11.97811.0676.8527.14118.536
带息债务/全部投入资本 (%)5.3744.093-0.584-0.715-0.280
股东权益/带息债务 (%)1,721.2602,304.434-16,868.760-13,673.838-34,575.586
股东权益/负债合计 (%)669.482731.2771,246.7891,199.940438.682
利息保障倍数 (X)-66.673-9.710-6.856-7.073-3.318

营运能力分析
应收账款周转天数 (天)115.535105.785106.06490.84586.988
存货周转天数 (天)214.875152.229119.869137.797146.421